Where is the evidence for the existence of the Cancer Drugs Fund?

被引:0
|
作者
Chamberlain, Charlotte [1 ]
Hollingworth, William [1 ]
机构
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 349卷
基金
美国国家卫生研究院;
关键词
D O I
10.1136/bmj.g5901
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Cancer Drugs Fund requires further reform
    Grieve, Richard
    Abrams, Keith
    Claxton, Karl
    Goldacre, Ben
    James, Nicholas
    Nicholl, Jon
    Parmar, Mahesh
    Parker, Chris
    Sekhon, Jasjeet S.
    Smeeth, Liam
    Spiegelhalter, David
    Sculpher, Mark
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [22] Which way now for the Cancer Drugs Fund?
    Jack, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [23] Cancer Drugs Fund 2.0: A Missed Opportunity?
    Christopher McCabe
    Ash Paul
    Greg Fell
    Mike Paulden
    PharmacoEconomics, 2016, 34 : 629 - 633
  • [24] Cutbacks at England's Cancer Drugs Fund
    不详
    CANCER DISCOVERY, 2015, 5 (04) : 338 - 339
  • [25] THE CANCER DRUGS FUND: THE EVOLVING ASSESSMENT PROCESS
    Carroll, M., V
    Satherley, A.
    Miller, P. S.
    VALUE IN HEALTH, 2016, 19 (07) : A757 - A757
  • [26] Cancer Drugs Fund 2.0: A Missed Opportunity?
    McCabe, Christopher
    Paul, Ash
    Fell, Greg
    Paulden, Mike
    PHARMACOECONOMICS, 2016, 34 (07) : 629 - 633
  • [27] No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog
    Kmietowicz, Zosia
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [28] A mixed methods study on the prioritisation of cancer and access to cancer drugs: the Cancer Drugs Fund in England
    Chamberlain, Charlotte
    Owen-Smith, Amanda
    Donovan, Jenny L.
    Hounsome, Luke
    Collin, Simon M.
    Hollingworth, William
    LANCET, 2015, 386 : S17 - S17
  • [29] NICE recommends dropping two drugs from Cancer Drugs Fund
    Hawkes, Nigel
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [30] THE IMPACT OF CANCER DRUGS FUND REFORMS ON REIMBURSEMENT OF ONCOLOGY DRUGS IN THE UK
    Macaulay, R.
    Dave, K.
    Walsh, S. C.
    VALUE IN HEALTH, 2017, 20 (09) : A461 - A461